Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Feb 1;345(Pt 3):573–581.

Disulphide-bond pattern and molecular modelling of the dimeric disintegrin EMF-10, a potent and selective integrin alpha5beta1 antagonist from Eristocophis macmahoni venom.

J J Calvete 1, M Jürgens 1, C Marcinkiewicz 1, A Romero 1, M Schrader 1, S Niewiarowski 1
PMCID: PMC1220792  PMID: 10642516

Abstract

The disulphide-bond pattern of the heterodimeric disintegrin EMF-10, a potent and selective integrin alpha(5)beta(1) antagonist from Eristocophis macmahoni venom, was established by combination of amino-acid analysis, N-terminal sequencing and collision-induced dissociation by nanoelectrospray ionization quadrupole ion-trap MS of fragments isolated by reversed-phase HPLC after degradation of EMF-10 with oxalic acid. Each EMF-10 subunit contains four intrachain disulphide bonds. Two interchain cystine residues join the EMF-10 polypeptides. The intrachain linkages are conserved in monomeric disintegrins. A molecular model of EMF-10 was built using averaged NMR co-ordinates of flavoridin as a template. The active hairpin loops of the EMF-10 subunits occupy opposite locations at the ends of an elongated disulphide-bond ladder. In the EMF-10 model the N-terminal polypeptide of EMF-10B is close to the RGD-loop of the EMF-10A subunit, suggesting that the N-terminal region of the B-subunit could potentially influence the biological activity of the A-subunit.

Full Text

The Full Text of this article is available as a PDF (178.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler M., Lazarus R. A., Dennis M. S., Wagner G. Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist. Science. 1991 Jul 26;253(5018):445–448. doi: 10.1126/science.1862345. [DOI] [PubMed] [Google Scholar]
  2. Bauer M., Sun Y., Degenhardt C., Kozikowski B. Assignment of all four disulfide bridges in echistatin. J Protein Chem. 1993 Dec;12(6):759–764. doi: 10.1007/BF01024934. [DOI] [PubMed] [Google Scholar]
  3. Biemann K. Contributions of mass spectrometry to peptide and protein structure. Biomed Environ Mass Spectrom. 1988 Oct;16(1-12):99–111. doi: 10.1002/bms.1200160119. [DOI] [PubMed] [Google Scholar]
  4. Calvete J. J., Schrader M., Raida M., McLane M. A., Romero A., Niewiarowski S. The disulphide bond pattern of bitistatin, a disintegrin isolated from the venom of the viper Bitis arietans. FEBS Lett. 1997 Oct 20;416(2):197–202. doi: 10.1016/s0014-5793(97)01203-9. [DOI] [PubMed] [Google Scholar]
  5. Calvete J. J., Schäfer W., Soszka T., Lu W. Q., Cook J. J., Jameson B. A., Niewiarowski S. Identification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venom of Trimeresurus albolabris: significance for the expression of platelet aggregation inhibitory activity. Biochemistry. 1991 May 28;30(21):5225–5229. doi: 10.1021/bi00235a016. [DOI] [PubMed] [Google Scholar]
  6. Calvete J. J., Wang Y., Mann K., Schäfer W., Niewiarowski S., Stewart G. J. The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett. 1992 Sep 14;309(3):316–320. doi: 10.1016/0014-5793(92)80797-k. [DOI] [PubMed] [Google Scholar]
  7. Caporale C., Sepe C., Caruso C., Pucci P., Buonocore V. Assignment of protein disulphides by a computer method using mass spectrometric data. FEBS Lett. 1996 Sep 16;393(2-3):241–247. doi: 10.1016/0014-5793(96)00894-0. [DOI] [PubMed] [Google Scholar]
  8. Dennis M. S., Carter P., Lazarus R. A. Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: analysis by site-directed mutagenesis. Proteins. 1993 Mar;15(3):312–321. doi: 10.1002/prot.340150308. [DOI] [PubMed] [Google Scholar]
  9. Gan Z. R., Gould R. J., Jacobs J. W., Friedman P. A., Polokoff M. A. Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem. 1988 Dec 25;263(36):19827–19832. [PubMed] [Google Scholar]
  10. Huang T. F., Holt J. C., Lukasiewicz H., Niewiarowski S. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J Biol Chem. 1987 Nov 25;262(33):16157–16163. [PubMed] [Google Scholar]
  11. Huang T. F., Peng H. C., Peng I. S., Teng C. M., Ouyang C. An antiplatelet peptide, gabonin, from Bitis gabonica snake venom. Arch Biochem Biophys. 1992 Oct;298(1):13–20. doi: 10.1016/0003-9861(92)90087-d. [DOI] [PubMed] [Google Scholar]
  12. Marcinkiewicz C., Calvete J. J., Marcinkiewicz M. M., Raida M., Vijay-Kumar S., Huang Z., Lobb R. R., Niewiarowski S. EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits alpha4 and alpha5 integrins in an RGD-independent manner. J Biol Chem. 1999 Apr 30;274(18):12468–12473. doi: 10.1074/jbc.274.18.12468. [DOI] [PubMed] [Google Scholar]
  13. Marcinkiewicz C., Calvete J. J., Vijay-Kumar S., Marcinkiewicz M. M., Raida M., Schick P., Lobb R. R., Niewiarowski S. Structural and functional characterization of EMF10, a heterodimeric disintegrin from Eristocophis macmahoni venom that selectively inhibits alpha 5 beta 1 integrin. Biochemistry. 1999 Oct 5;38(40):13302–13309. doi: 10.1021/bi9906930. [DOI] [PubMed] [Google Scholar]
  14. Marcinkiewicz C., Vijay-Kumar S., McLane M. A., Niewiarowski S. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site. Blood. 1997 Aug 15;90(4):1565–1575. [PubMed] [Google Scholar]
  15. Markland F. S. Snake venoms and the hemostatic system. Toxicon. 1998 Dec;36(12):1749–1800. doi: 10.1016/s0041-0101(98)00126-3. [DOI] [PubMed] [Google Scholar]
  16. Marrakchi N., Barbouche R., Bon C., el Ayeb M. Cerastatin, a new potent inhibitor of platelet aggregation from the venom of the Tunisian viper, Cerastes cerastes. Toxicon. 1997 Jan;35(1):125–135. doi: 10.1016/s0041-0101(96)00020-7. [DOI] [PubMed] [Google Scholar]
  17. McLane M. A., Marcinkiewicz C., Vijay-Kumar S., Wierzbicka-Patynowski I., Niewiarowski S. Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med. 1998 Nov;219(2):109–119. doi: 10.3181/00379727-219-44322. [DOI] [PubMed] [Google Scholar]
  18. McLane M. A., Vijay-Kumar S., Marcinkiewicz C., Calvete J. J., Niewiarowski S. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins. FEBS Lett. 1996 Aug 5;391(1-2):139–143. doi: 10.1016/0014-5793(96)00716-8. [DOI] [PubMed] [Google Scholar]
  19. Pfaff M., McLane M. A., Beviglia L., Niewiarowski S., Timpl R. Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition. Cell Adhes Commun. 1994 Dec;2(6):491–501. doi: 10.3109/15419069409014213. [DOI] [PubMed] [Google Scholar]
  20. Rahman S., Aitken A., Flynn G., Formstone C., Savidge G. F. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation. Biochem J. 1998 Oct 15;335(Pt 2):247–257. doi: 10.1042/bj3350247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Saudek V., Atkinson R. A., Pelton J. T. Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry. 1991 Jul 30;30(30):7369–7372. doi: 10.1021/bi00244a003. [DOI] [PubMed] [Google Scholar]
  22. Scarborough R. M., Rose J. W., Naughton M. A., Phillips D. R., Nannizzi L., Arfsten A., Campbell A. M., Charo I. F. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem. 1993 Jan 15;268(2):1058–1065. [PubMed] [Google Scholar]
  23. Senn H., Klaus W. The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. J Mol Biol. 1993 Aug 5;232(3):907–925. doi: 10.1006/jmbi.1993.1439. [DOI] [PubMed] [Google Scholar]
  24. Smith K. J., Jaseja M., Lu X., Williams J. A., Hyde E. I., Trayer I. P. Three-dimensional structure of the RGD-containing snake toxin albolabrin in solution, based on 1H NMR spectroscopy and simulated annealing calculations. Int J Pept Protein Res. 1996 Sep;48(3):220–228. doi: 10.1111/j.1399-3011.1996.tb00835.x. [DOI] [PubMed] [Google Scholar]
  25. Trikha M., De Clerck Y. A., Markland F. S. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res. 1994 Sep 15;54(18):4993–4998. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES